Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLiontrust Asset Management Regulatory News (LIO)

Share Price Information for Liontrust Asset Management (LIO)

Share Price is delayed by 15 minutes
Get Live Data
311.50    1.00 (0.32%)
Bid:
311.50
Ask:
313.50
Spread: 2.00 (0.642%)
Market Cap: £186.24m
LIO Live PriceLast checked at - London Stock Exchange

Intraday Liontrust Asset Management Share Chart

Share Buyback Programme

28 Nov 2024 07:00

RNS Number : 9102N
Liontrust Asset Management PLC
28 November 2024
Β 

LEI: 549300XVXU6S7PLCL855

Β 

28 November 2024

Β 

Liontrust Asset Management Plc

Β 

("Liontrust" or the "Company")

Β 

Share Buyback Programme

Β 

Liontrust announces that it intends to conduct on-market purchases under a share buybackΒ programme toΒ repurchase ordinary shares of 1p eachΒ in the capital of the Company (the "Ordinary Shares") equating to up to Β£5 million (the "Buyback").

The Company has appointedΒ Singer Capital Markets Securities LimitedΒ ("Singer Capital Markets") to execute and manage the Buyback and has given an irrevocable instruction toΒ Singer Capital MarketsΒ to make market purchases of Ordinary Shares on its behalf independently to the Company. The Buyback will be conducted in accordance withΒ Article 5(1) of Regulation (EU) No 596/2014,Β further to which the Company will not purchase on any trading day more than 75,000 Ordinary Shares. TheΒ BuybackΒ will run from the date of this announcement to 31 March 2025, unless terminated earlier.Β Singer Capital MarketsΒ will make its trading decisions in relation to the Ordinary Shares independently of the Company.Β 

The Company intends to conduct theΒ BuybackΒ within the limitations of the shareholder authority granted at the Company's AGM held onΒ 19 September 2024, under which the maximumΒ price which may be paid by the Company per Ordinary Share shall not be moreΒ than the lower ofΒ 5 per cent above the average middle market quotations for an Ordinary Share (as derived from the London Stock Exchange Daily Official List) for the five business days immediately preceding the date of repurchase, and the higher of the price of the last independent trade and the highest current independent bid for an Ordinary Share.Β 

TheΒ BuybackΒ will be funded from the Company's existing cash resources and all Ordinary Shares repurchased will be cancelled, with the purpose of the Buyback being to reduce the Company's issued share capital.Β Repurchases may be made up to and includingΒ 31 March 2025.

There is no guarantee that theΒ BuybackΒ programme will be implemented in full or that any repurchases will be made.Β 

As at the time of this announcement, the Company's total issued share capital consists ofΒ 64,935,384Β Ordinary Shares with one voting right per share. The Company does not hold any shares in treasury. Therefore, the total number of voting rights in the Company isΒ 64,935,384.

The above figure of 64,935,384 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under theΒ FCA'sΒ Disclosure Guidance and Transparency Rules.

For further information please contact:

Teneo (Tel: 020 7353 4200, Email:Β liontrust@teneo.com)

Tom Murray,Β Colette Cahill,Β Jessica Pine

Β 

Liontrust Asset Management PlcΒ (Tel:Β 020 7412 1700, Website: liontrust.co.uk)

Stephen Corbett: Head of Investor Relations

Simon Hildrey: Chief Marketing Officer

Β 

Singer Capital MarketsΒ (Tel: 020 7496 3000)

Corporate Broking:Β Charles Leigh-Pemberton

Corporate Advisory:Β James Moat

Β 

Panmure Liberum (Tel: 020 7886 2500)

Corporate Broking:Β David Watkins

Corporate Advisory:Β Atholl Tweedie

Β 

HSBC Bank plcΒ (Tel: 020 7991 8888)

Corporate Broking:Β Simon Alexander,Β James Hopton

Corporate Advisory:Β Alexander Paul

Β 

END

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCFLFIRLALDFIS
Date   Source Headline
2nd Feb 20267:05 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20263:22 pmRNSForm 8.3 -KITWAVE GROUP PLC
29th Jan 20263:19 pmRNSForm 8.3 - Auction Technology Group
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20262:45 pmRNSForm 8.3 - Oxford Biomedica Plc
28th Jan 20262:40 pmRNSForm 8.3 - Kitwave Group Plc
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20263:25 pmRNSForm 8.3 - Auction Technology Group Plc
26th Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20262:08 pmRNSForm 8.3 - Oxford Biomedica Plc
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20264:40 pmRNSForm 8.3 - Auction Technology Group PLC
14th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTrading Statement
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20263:17 pmRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20263:29 pmRNSHolding(s) in Company
2nd Jan 202611:08 amRNSTotal Voting Rights
23rd Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20254:00 pmRNSDirector/PDMR Shareholding
19th Dec 20254:00 pmRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20255:44 pmRNSForm 8.3 - INSPECS GROUP PLC
12th Dec 20255:27 pmRNSForm 8.3 - INSPECS GROUP PLC
11th Dec 20251:42 pmRNSForm 8.3 - INSPECS GROUP PLC
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20253:03 pmRNSForm 8.3 - INSPECS GROUP PLC
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20253:36 pmRNSForm 8.3 - INSPECS GROUP PLC
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20254:02 pmRNSForm 8.3 - ESSENSYS PLC
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20252:23 pmRNSForm 8.3 - INSPECS GROUP PLC
2nd Dec 20251:19 pmRNSForm 8.3 - INSPECS GROUP PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.